What we still don’t know about weight-loss drugs

What we still don’t know about weight-loss drugs

MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next. You can read more from the series here. Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *